Drug treatment strategies for insomnia in patients with post-traumatic stress disorder.

Drug treatment strategies for insomnia in patients with post-traumatic stress disorder.
Expert Opin Pharmacother. 2019 Feb 22;:1-9
Authors: Akinnusi M, El Solh AA
Abstract
INTRODUCTION: Insomnia is among the most reported sleep disturbances in patients with post-traumatic stress disorder (PTSD). The pervasiveness of this disorder among trauma-inflicted civilians and military personnel has been associated with reduced quality of life, impaired psychosocial functioning including cognitive impairments, negative mood swings, cardiovascular complications, and increased utilization of medical services. Areas covered: This review describes the current state of science with respect to the impact of the most dispensed pharmacological interventions for posttraumatic insomnia. At the present, there are no established treatment algorithms for PTSD-related insomnia. Pharmacotherapy offers an alternative treatment modality for patients with PTSD who fail or decline cognitive behavioral therapy (CBT). Selection of a hypnotic/sedative agent should be based on the patient's history, precipitating and perpetuating factors of insomnia, side effect profile, and potential medication-related interactions. Antipsychotics and benzodiazepines appear ineffective or are associated with significant harm in treating PTSD-related insomnia. Expert opinion: In the absence of randomized controlled trials, prescription patterns have been guided by anecdotal reports a...

Source: Expert Opinion on Pharmacotherapy - February 24, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research